Acute effects of estradiol on circulating luteinizing hormone and prolactin concentrations and on serotonin turnover in individual brain nuclei.
Two experiments tested whether serotonergic neurons participate in the acute feedback effects of estradiol on LH and PRL secretion. In the first study, ovariectomized female rats received oil vehicle or estradiol benzoate and were killed 3 h later. The turnover of serotonin [5-hydroxytryptamine (5-HT)] in microdissected brain nuclei was assessed from its accumulation after monoamine oxidase inhibition. Estradiol treatment produced a gradual rise in PRL and a decline in LH, and potentiated the accumulation of 5-HT in the medial preoptic, ventromedial, and cortical amygdaloid nuclei, suggesting increased turnover. Concentrations of the metabolite, 5-hydroxyindole acetic acid, were also elevated in these areas. 5-HT turnover was unaffected by estradiol in the interstitial nucleus of the stria terminalis, periventricular, dorsomedial, or lateral amygdaloid nuclei. The second experiment tested whether localized 5-HT depletions in these estradiol-activated nuclei blocked the acute effects of the steroid on LH or PRL. Stereotaxic microinjections of the 5-HT neurotoxin, 5,7, dihydroxytryptamine were made into the preoptic area, cortical amygdala, or medial basal hypothalamus in ovariectomized rats, pretreated with desmethylimipramine. Such treatment reduced 5-HT, without affecting catecholamines, in the targeted structures. Localized 5-HT depletion in the preoptic area and amygdala blunted the elevation of PRL, but not the decline of LH, after estradiol. 5-HT depletion in the medial basal hypothalamus elevated, whereas 5-HT depletion in the medial preoptic area lowered, resting levels of LH. These results suggest that: 1) estradiol may acutely increase PRL secretion by activating serotonergic projections to the medial preoptic and cortical amygdaloid nuclei, and 2) serotonergic neurons innervating the preoptic area stimulate LH release, whereas serotonergic systems in the medial basal hypothalamus inhibit LH release.
D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology; D000679:Amygdala / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D007031:Hypothalamus / Q000378:metabolism; D007986:Luteinizing Hormone / Q000097:blood*; D011388:Prolactin / Q000097:blood*; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000378:metabolism*
D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone